BackAveanna Healthcare Holdings Overview

Aveanna Healthcare Holdings EBIT

Latest ebit for AVAH: $220M, below the Healthcare sector average of $22B.

Get informed when a big investor buys or sells

+ Follow

Quarterly EBIT

$84.25M
5.13% YoY

As of Jun 30, 2026

Annual EBIT (TTM)

$217.05M
914.85% YoY

Trailing 12 months ending Jun 30, 2026

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Aveanna Healthcare Holdings (AVAH) FAQ

The latest EBIT for AVAH is $220M as of June 2026. That compares with $21M in the prior-year period — up 914.9% year over year. That is below the Healthcare sector average of $22B. Investors often review this figure alongside Aveanna Healthcare Holdings's historical trend and sector peers before judging valuation or financial health.

Over the past year, AVAH's EBIT moved from $21M to $220M — a 914.9% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Aveanna Healthcare Holdings's operating scale or balance-sheet position.

Against Healthcare companies, AVAH currently prints $220M for EBIT, while the sector average sits near $22B. That is roughly 99.0% below the sector mean. Large gaps often invite a closer look at Aveanna Healthcare Holdings's growth, margins, and balance sheet.

A EBIT figure of $220M for AVAH is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The Healthcare average is about $22B. Explore the charts below for those layers of context.

After noting AVAH's EBIT ($220M), review year-over-year change from $21M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.